Company Filing History:
Years Active: 2023
Title: Eric Lindberg - Innovator in Kinase Inhibitors
Introduction
Eric Lindberg is an inventor based in Rockville, MD (US). He is known for his work in the field of kinase inhibitors, which are crucial in the treatment of various diseases. Although he currently holds no granted patents, his innovative ideas are reflected in his latest patent applications.
Latest Patent Applications
Eric Lindberg has submitted several notable patent applications. One of his latest applications is for "MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE." This application discloses compounds that inhibit kinase activity and may be used to treat diseases characterized by the overexpression of one or more mixed lineage kinases (MLKs). The compounds are described to have a structure according to formula I, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof.
Another significant application is for "LZK-TARGETING DEGRADERS AND METHODS OF USE." This application reveals leucine zipper-bearing kinase (LZK) targeted degraders. The compounds have a general formula Q-L-Z, where Q is an LZK binding moiety, L is a linker, and Z is an E3-ligase binding moiety. These compounds are designed to inhibit LZK activity and/or degrade LZK, potentially treating diseases characterized by LZK overexpression.
Conclusion
Eric Lindberg is an innovative inventor whose work in kinase inhibitors shows promise for future medical applications. His latest patent applications reflect his commitment to advancing treatment options for diseases linked to kinase activity.